跳至主要内容
临床试验/CTRI/2025/08/093059
CTRI/2025/08/093059尚未招募2 期

A clinico comparative study of pramehahar kashaya ghanavati and katak khadiradi kashaya ghanavati in the management of madhumeha with special reference to diabetes mellitus DM type 2

Pt khushilal sharma govt autonomous ayurveda college and institue bhopal1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年9月1日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
It is expected that at the end of the study we will be able to evaluate the efficacy of pramehahar kashaya ghanavati and katak khadiradi kashaya ghanavati in madhumeha with special reference to Diabetes Melitus Type 2.

研究概览

简要总结

It is expected that at the end of the study we will be able to evaluate the efficacy of pramehahar kashaya ghanavati and katak khadiradi kashaya ghanavati in madhumeha with special reference to diabetes melitus type 2

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
31.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Fasting plasma glucose more than 126 mg per dl and less than or equal to 200mg per dl.
  • Or post load plasma glucose more than 200 mg per dl and less than or equal to 350 mg per dl.
  • Or HbA1c more than 6.5 percent and less than or eual to 10 percent.
  • Recently diagnosed cases of DM
  • Patient who will give written consent to participate.

排除标准

  • Malignant and accelerated hypertension CVS disorder (CAD) Pregnant women and lactating mother CNS disorder e.g., encephalopathy etc.

结局指标

主要结局

It is expected that at the end of the study we will be able to evaluate the efficacy of pramehahar kashaya ghanavati and katak khadiradi kashaya ghanavati in madhumeha with special reference to Diabetes Melitus Type 2.

时间窗: 12 months

次要结局

未报告次要终点

研究者

发起方
Pt khushilal sharma govt autonomous ayurveda college and institue bhopal
申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Dr Pooja Maida

pt. khushilal sharma govt autonomous ayurveda college and institue bhopal mp

研究点 (1)

Loading locations...

相似试验